SCHEMBL25720185

SCHEMBL25720185

Cc1cccc(C)c1Nc1ccccc1CC(=O)OCCOCCN

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 7/20 0.57
▸ TTR P02766 3/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ USP2 O75604 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ TBXA2R P21731 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ CXCL8 P10145 2/20 0.40
▸ CLIC1 O00299 1/20 0.40
▸ CLCN2 P51788 1/20 0.40
▸ PTGS1 P23219 2/20 0.40
▸ AKR1B10 O60218 1/20 0.40
▸ UGT1A9 O60656 1/20 0.40
▸ TRPA1 O75762 1/20 0.40
▸ ABCB11 O95342 1/20 0.40
▸ MT-CO2 P00403 1/20 0.40
▸ ALB P02768 1/20 0.40
▸ UGT1A6 P19224 1/20 0.40
▸ UGT1A1 P22309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13299158 0.86 TTR (0.65) PTGS2TTRCYP2C9USP2LMNA
SCHEMBL11567028 0.80 PTGS2 (0.73) PTGS2TTRCYP2C9USP2LMNA
SCHEMBL17001514 0.78 TTR (0.71) PTGS2TTRCYP2C9USP2LMNA
SCHEMBL11564032 0.77 PTGS2 (0.61) PTGS2TTRCYP2C9USP2LMNA
SCHEMBL13777335 0.77 TTR (0.65) PTGS2TTRCYP2C9USP2LMNA
SCHEMBL13299178 0.77 TTR (0.65) PTGS2TTRCYP2C9USP2LMNA
SCHEMBL13109328 0.77 TTR (0.65) PTGS2TTRCYP2C9USP2LMNA
SCHEMBL10310898 0.77 TTR (0.65) PTGS2TTRCYP2C9USP2LMNA
SCHEMBL23158819 0.76 TTR (0.58) PTGS2TTRCYP2C9USP2LMNA
SCHEMBL13911458 0.76 PTGS2 (0.50) PTGS2TTRCYP2C9USP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230190943-A1 ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230190943-A1 ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND ALG1, ALG8, ALG3 PTGS2 163/4885TTR 4779/4885CYP2C9 3313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback